SEC-sourced researchBeta
ATRC
AtriCure, Inc.
Company comparison ↗
Data passport
- CIK
- 0001323885
- Exchange
- Nasdaq
- Business activity
- Surgical & Medical Instruments & Apparatus · SIC 3841
- Financial inputs
- 6/6
- Filing date
- Oct 5, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 399,245,000.0000 | Feb 19, 2026 |
| December 2024 | 465,307,000.0000 | Feb 19, 2026 |
| December 2025 | 534,528,000.0000 | Feb 19, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 534,528,000.0000 | -11,448,000.0000 | 57,334,000.0000 | 654,179,000.0000 | 162,244,000.0000 | Feb 19, 2026 |
| December 2024 | 465,307,000.0000 | -44,698,000.0000 | 12,204,000.0000 | 609,328,000.0000 | 148,359,000.0000 | Feb 19, 2026 |
| December 2023 | 399,245,000.0000 | -30,438,000.0000 | 4,484,000.0000 | — | — | Feb 19, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
71/100
Profitability46
Growth65
Balance sheet75
Cash generation71
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $534.53M | Jan 1, 2025 – Dec 31, 2025 | Feb 19, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $465.31M | Jan 1, 2024 – Dec 31, 2024 | Feb 19, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$11.45M | Jan 1, 2025 – Dec 31, 2025 | Feb 19, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $57.33M | Jan 1, 2025 – Dec 31, 2025 | Feb 19, 2026 | 10-K |
| Total assetsAssets | $654.18M | Dec 31, 2025 | Feb 19, 2026 | 10-K |
| Total liabilitiesLiabilities | $162.24M | Dec 31, 2025 | Feb 19, 2026 | 10-K |
New filings
- SCHEDULE 13G/AATRC · AtriCure, Inc.Oct 5, 2026 · Other
- 4ATRC · AtriCure, Inc.Sep 24, 2026 · Other
- 144ATRC · AtriCure, Inc.Sep 23, 2026 · Other
- 4ATRC · AtriCure, Inc.Sep 14, 2026 · Other
- 144ATRC · AtriCure, Inc.Sep 11, 2026 · Other
- 4ATRC · AtriCure, Inc.Sep 10, 2026 · Other
- 144ATRC · AtriCure, Inc.Sep 8, 2026 · Other
- 4ATRC · AtriCure, Inc.Sep 4, 2026 · Other
- 144ATRC · AtriCure, Inc.Sep 2, 2026 · Other
- 4ATRC · AtriCure, Inc.Aug 26, 2026 · Other
- 144ATRC · AtriCure, Inc.Aug 24, 2026 · Other
- SCHEDULE 13G/AATRC · AtriCure, Inc.Aug 14, 2026 · Other
- 4ATRC · AtriCure, Inc.Aug 7, 2026 · Other
- 4ATRC · AtriCure, Inc.Aug 7, 2026 · Other
- 144ATRC · AtriCure, Inc.Aug 5, 2026 · Other
- 144ATRC · AtriCure, Inc.Aug 5, 2026 · Other
- 4ATRC · AtriCure, Inc.Aug 3, 2026 · Other
- 4ATRC · AtriCure, Inc.Jul 30, 2026 · Other
- 4ATRC · AtriCure, Inc.Jul 30, 2026 · Other
- 4ATRC · AtriCure, Inc.Jul 30, 2026 · Other